Targeting glioblastoma stem cells: Cell surface markers

Current Medicinal Chemistry

Volumn 19, Issue 35, 2012, Pages 6050-6055

  He, J ^a   Liu, Y ^b   Lubman, D M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b SRI INTERNATIONAL   (United States)

Author keywords

Cell surface markers; Glioblastoma stem cell; Proteomics; Therapeutic target

Indexed keywords

A2B5 PROTEIN; ALPHA6 INTEGRIN; CD133 ANTIGEN; CD15 ANTIGEN; CELL ADHESION MOLECULE; CELL SURFACE MARKER; L1 CELL ADHESION MOLECULE; NESTIN; THY 1 ANTIGEN; TRANSCRIPTION FACTOR EZH2; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ARTICLE; CANCER STEM CELL; CELL FUNCTION; CELL PROLIFERATION; GLIOBLASTOMA; HUMAN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TARGETING; PROTEOMICS; QUANTITATIVE ANALYSIS; STEM CELL NICHE; TUMOR GROWTH;

BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; MEMBRANE PROTEINS; NEOPLASTIC STEM CELLS; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 84871290091     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712804485944     Document Type: Article

References (87)

1. Reya, T.; Morrison, S. J.; Clarke, M. F.; Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature, 2001, 414, 105-111
2. Lapidot, T.; Sirard, C.; Vormoor, J.; Murdoch, B.; Hoang, T.; Caceres-Cortes, J.; Minden, M.; Paterson, B.; Caligiuri, M. A.; Dick, J. E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature, 1994, 367, 645-648
3. Visvader, J. E.; Lindeman, G. J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer, 2008, 8, 755-768
4. Al-Hajj, M.; Wicha, M. S.; Benito-Hernandez, A.; Morrison, S. J.; Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A, 2003, 100, 3983-3988
5. He, J.; Liu, Y.; He, S.; Wang, Q.; Pu, H.; Ji, J. Proteomic analysis of a membrane skeleton fraction from human liver. J Proteome Res, 2007, 6, 3509-3518
6. Patrawala, L.; Calhoun, T.; Schneider-Broussard, R.; Li, H.; Bhatia, B.; Tang, S.; Reilly, J. G.; Chandra, D.; Zhou, J.; Claypool, K.; Coghlan, L.; Tang, D. G. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene, 2006, 25, 1696-1708
7. O'Brien, C. A.; Pollett, A.; Gallinger, S.; Dick, J. E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 2007, 445, 106-110
8. Ricci-Vitiani, L.; Lombardi, D. G.; Pilozzi, E.; Biffoni, M.; Todaro, M.; Peschle, C.; De Maria, R. Identification and expansion of human coloncancer-initiating cells. Nature, 2007, 445, 111-115
9. Singh, S. K.; Hawkins, C.; Clarke, I. D.; Squire, J. A.; Bayani, J.; Hide, T.; Henkelman, R. M.; Cusimano, M. D.; Dirks, P. B. Identification of human brain tumour initiating cells. Nature, 2004, 432, 396-401
10. Galli, R.; Binda, E.; Orfanelli, U.; Cipelletti, B.; Gritti, A.; De Vitis, S.; Fiocco, R.; Foroni, C.; Dimeco, F.; Vescovi, A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res, 2004, 64, 7011-7021
11. Ignatova, T. N.; Kukekov, V. G.; Laywell, E. D.; Suslov, O. N.; Vrionis, F. D.; Steindler, D. A. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia, 2002, 39, 193-206
12. Yuan, X.; Curtin, J.; Xiong, Y.; Liu, G.; Waschsmann-Hogiu, S.; Farkas, D. L.; Black, K. L.; Yu, J. S. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene, 2004, 23, 9392-9400
13. Singh, S. K.; Clarke, I. D.; Terasaki, M.; Bonn, V. E.; Hawkins, C.; Squire, J.; Dirks, P. B. Identification of a cancer stem cell in human brain tumors. Cancer Res, 2003, 63, 5821-5828
14. Bao, S.; Wu, Q.; McLendon, R. E.; Hao, Y.; Shi, Q.; Hjelmeland, A. B.; Dewhirst, M. W.; Bigner, D. D.; Rich, J. N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 2006, 444, 756-760
15. Maher, E. A.; Furnari, F. B.; Bachoo, R. M.; Rowitch, D. H.; Louis, D. N.; Cavenee, W. K.; De Pinho, R. A. Malignant glioma: genetics and biology of a grave matter. Genes Dev, 2001, 15, 1311-1333
16. Vescovi, A. L.; Galli, R.; Reynolds, B. A. Brain tumour stem cells. Nat Rev Cancer, 2006, 6, 425-436
17. Tabatabai, G.; Weller, M. Glioblastoma stem cells. Cell Tissue Res, 2011, 343, 459-465
18. Rich, J. N. Cancer stem cells in radiation resistance. Cancer Res, 2007, 67, 8980-8984
19. Liu, G.; Yuan, X.; Zeng, Z.; Tunici, P.; Ng, H.; Abdulkadir, I. R.; Lu, L.; Irvin, D.; Black, K. L.; Yu, J. S. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer, 2006, 5, 67
20. Eyler, C. E.; Rich, J. N. Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. J Clin Oncol, 2008, 26, 2839-2845
21. Liu, S.; Wicha, M. S. Targeting breast cancer stem cells. J Clin Oncol, 2010, 28, 4006-4012
22. Yilmaz, O. H.; Valdez, R.; Theisen, B. K.; Guo, W.; Ferguson, D. O.; Wu, H.; Morrison, S. J. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature, 2006, 441, 475-482
23. Takebe, N.; Harris, P. J.; Warren, R. Q.; Ivy, S. P. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Oncol, 2011, 8, 97-106
24. Piccirillo, S. G.; Reynolds, B. A.; Zanetti, N.; Lamorte, G.; Binda, E.; Broggi, G.; Brem, H.; Olivi, A.; Dimeco, F.; Vescovi, A. L. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature, 2006, 444, 761-765
25. Bao, S.; Wu, Q.; Li, Z.; Sathornsumetee, S.; Wang, H.; McLendon, R. E.; Hjelmeland, A. B.; Rich, J. N. Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res, 2008, 68, 6043-6048
26. Overington, J. P.; Al-Lazikani, B.; Hopkins, A. L. How many drug targets are there? Nat Rev Drug Discov, 2006, 5, 993-996
27. Miraglia, S.; Godfrey, W.; Yin, A. H.; Atkins, K.; Warnke, R.; Holden, J. T.; Bray, R. A.; Waller, E. K.; Buck, D. W. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood, 1997, 90, 5013-5021
28. Yin, A. H.; Miraglia, S.; Zanjani, E. D.; Almeida-Porada, G.; Ogawa, M.; Leary, A. G.; Olweus, J.; Kearney, J.; Buck, D. W. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood, 1997, 90, 5002-5012
29. Bao, S.; Wu, Q.; Sathornsumetee, S.; Hao, Y.; Li, Z.; Hjelmeland, A. B.; Shi, Q.; McLendon, R. E.; Bigner, D. D.; Rich, J. N. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res, 2006, 66, 7843-7848
30. Beier, D.; Hau, P.; Proescholdt, M.; Lohmeier, A.; Wischhusen, J.; Oefner, P. J.; Aigner, L.; Brawanski, A.; Bogdahn, U.; Beier, C. P. CD133 (+) and CD133 (-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res, 2007, 67, 4010-4015
31. Wang, J.; Sakariassen, P. O.; Tsinkalovsky, O.; Immervoll, H.; Boe, S. O.; Svendsen, A.; Prestegarden, L.; Rosland, G.; Thorsen, F.; Stuhr, L.; Molven, A.; Bjerkvig, R.; Enger, P. O. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer, 2008, 122, 761-768
32. Joo, K. M.; Kim, S. Y.; Jin, X.; Song, S. Y.; Kong, D. S.; Lee, J. I.; Jeon, J. W.; Kim, M. H.; Kang, B. G.; Jung, Y.; Jin, J.; Hong, S. C.; Park, W. Y.; Lee, D. S.; Kim, H.; Nam, D. H. Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab Invest, 2008, 88, 808-815
33. Chen, R.; Nishimura, M. C.; Bumbaca, S. M.; Kharbanda, S.; Forrest, W. F.; Kasman, I. M.; Greve, J. M.; Soriano, R. H.; Gilmour, L. L.; Rivers, C. S.; Modrusan, Z.; Nacu, S.; Guerrero, S.; Edgar, K. A.; Wallin, J. J.; Lamszus, K.; Westphal, M.; Heim, S.; James, C. D.; Van Den Berg, S. R.; Costello, J. F.; Moorefield, S.; Cowdrey, C. J.; Prados, M.; Phillips, H. S. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell, 2010, 17, 362-375
34. Uchida, N.; Buck, D. W.; He, D.; Reitsma, M. J.; Masek, M.; Phan, T. V.; Tsukamoto, A. S.; Gage, F. H.; Weissman, I. L. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A, 2000, 97, 14720-14725
35. Hall, P. E.; Lathia, J. D.; Miller, N. G.; Caldwell, M. A.; Ffrench-Constant, C. Integrins are markers of human neural stem cells. Stem Cells, 2006, 24, 2078-2084
36. Lathia, J. D.; Gallagher, J.; Heddleston, J. M.; Wang, J.; Eyler, C. E.; Macswords, J.; Wu, Q.; Vasanji, A.; McLendon, R. E.; Hjelmeland, A. B.; Rich, J. N. Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell, 2010, 6, 421-432
37. Capela, A.; Temple, S. LeX/ssea-1 is expressed by adult mouse CNS stem cells, identifying them as nonependymal. Neuron, 2002, 35, 865-875
38. Capela, A.; Temple, S. LeX is expressed by principle progenitor cells in the embryonic nervous system, is secreted into their environment and binds Wnt-1. Dev Biol, 2006, 291, 300-313
39. Read, T. A.; Fogarty, M. P.; Markant, S. L.; McLendon, R. E.; Wei, Z.; Ellison, D. W.; Febbo, P. G.; Wechsler-Reya, R. J. Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma. Cancer Cell, 2009, 15, 135-147
40. Son, M. J.; Woolard, K.; Nam, D. H.; Lee, J.; Fine, H. A. SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell, 2009, 4, 440-452
41. Maness, P. F.; Schachner, M. Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration. Nat Neurosci, 2007, 10, 19-26
42. Rege, T. A.; Hagood, J. S. Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. FASEBJ, 2006, 20, 1045-1054
43. Baum, C. M.; Weissman, I. L.; Tsukamoto, A. S.; Buckle, A. M.; Peault, B. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci U S A, 1992, 89, 2804-2808
44. Dominici, M.; Le Blanc, K.; Mueller, I.; Slaper-Cortenbach, I.; Marini, F.; Krause, D.; Deans, R.; Keating, A.; Prockop, D.; Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 2006, 8, 315-317
45. Yang, Z. F.; Ho, D. W.; Ng, M. N.; Lau, C. K.; Yu, W. C.; Ngai, P.; Chu, P. W.; Lam, C. T.; Poon, R. T.; Fan, S. T. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell, 2008, 13, 153-166
46. He, J.; Liu, Y.; Xie, X.; Zhu, T.; Soules, M.; Di Meco, F.; Vescovi, A. L.; Fan, X.; Lubman, D. M. Identification of cell surface glycoprotein markers for glioblastoma-derived stem-like cells using a lectin microarray and LC-MS/MS approach. J Proteome Res, 2010, 9, 2565-2572
47. He, J.; Liu, Y.; Zhu, T.; Zhu, J.; Dimeco, F.; Vescovi, A. L.; Heth, J. A.; Muraszko, K. M.; Fan, X.; Lubman, D. M. CD90 is identified as a marker for cancer stem cells in primary high-grade gliomas using tissue microarrays. Mol Cell Proteomics, 2011
48. Bolot, G.; Popa, I.; Paret, M. J.; David, M. J.; Schmitt, D.; Portoukalian, J. A set of glycoproteins recognized by A2B5 antibody with major bands at 55 and 76 kDa is overexpressed in human head and neck squamous cell carcinomas. Biochimie, 2003, 85, 409-412
49. Inoko, E.; Nishiura, Y.; Tanaka, H.; Takahashi, T.; Furukawa, K.; Kitajima, K.; Sato, C. Developmental stage-dependent expression of an alpha2, 8-trisialic acid unit on glycoproteins in mouse brain. Glycobiology, 2010, 20, 916-928
50. Ogden, A. T.; Waziri, A. E.; Lochhead, R. A.; Fusco, D.; Lopez, K.; Ellis, J. A.; Kang, J.; Assanah, M.; McKhann, G. M.; Sisti, M. B.; McCormick, P. C.; Canoll, P.; Bruce, J. N. Identification of A2B5+CD133-tumor-initiating cells in adult human gliomas. Neurosurgery, 2008, 62, 505-514; discussion 514-505
51. Tchoghandjian, A.; Baeza, N.; Colin, C.; Cayre, M.; Metellus, P.; Beclin, C.; Ouafik, L.; Figarella-Branger, D. A2B5 cells from human glioblastoma have cancer stem cell properties. Brain Pathol, 2010, 20, 211-221
52. Lendahl, U.; Zimmerman, L. B.; McKay, R. D. CNS stem cells express a new class of intermediate filament protein. Cell, 1990, 60, 585-595
53. Dahlstrand, J.; Collins, V. P.; Lendahl, U. Expression of the class VI intermediate filament nestin in human central nervous system tumors. Cancer Res, 1992, 52, 5334-5341
54. Strojnik, T.; Rosland, G. V.; Sakariassen, P. O.; Kavalar, R.; Lah, T. Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. Surg Neurol, 2007, 68, 133-143; discussion 143-134
55. Guryanova, O. A.; Wu, Q.; Cheng, L.; Lathia, J. D.; Huang, Z.; Yang, J.; MacSwords, J.; Eyler, C. E.; McLendon, R. E.; Heddleston, J. M.; Shou, W.; Hambardzumyan, D.; Lee, J.; Hjelmeland, A. B.; Sloan, A. E.; Bredel, M.; Stark, G. R.; Rich, J. N.; Bao, S. Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3. Cancer Cell, 2011, 19, 498-511
56. Fong, H.; Hohenstein, K. A.; Donovan, P. J. Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells. Stem Cells, 2008, 26, 1931-1938
57. Bani-Yaghoub, M.; Tremblay, R. G.; Lei, J. X.; Zhang, D.; Zurakowski, B.; Sandhu, J. K.; Smith, B.; Ribecco-Lutkiewicz, M.; Kennedy, J.; Walker, P. R.; Sikorska, M. Role of Sox2 in the development of the mouse neocortex. Dev Biol, 2006, 295, 52-66
58. Gangemi, R. M.; Griffero, F.; Marubbi, D.; Perera, M.; Capra, M. C.; Malatesta, P.; Ravetti, G. L.; Zona, G. L.; Daga, A.; Corte, G. SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells, 2009, 27, 40-48
59. Ligon, K. L.; Huillard, E.; Mehta, S.; Kesari, S.; Liu, H.; Alberta, J. A.; Bachoo, R. M.; Kane, M.; Louis, D. N.; Depinho, R. A.; Anderson, D. J.; Stiles, C. D.; Rowitch, D. H. Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron, 2007, 53, 503-517
60. Abdouh, M.; Facchino, S.; Chatoo, W.; Balasingam, V.; Ferreira, J.; Bernier, G. BMI1 sustains human glioblastoma multiforme stem cell renewal. J Neurosci, 2009, 29, 8884-8896
61. Godlewski, J.; Nowicki, M. O.; Bronisz, A.; Williams, S.; Otsuki, A.; Nuovo, G.; Raychaudhury, A.; Newton, H. B.; Chiocca, E. A.; Lawler, S. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res, 2008, 68, 9125-9130
62. Suva, M. L.; Riggi, N.; Janiszewska, M.; Radovanovic, I.; Provero, P.; Stehle, J. C.; Baumer, K.; Le Bitoux, M. A.; Marino, D.; Cironi, L.; Marquez, V. E.; Clement, V.; Stamenkovic, I. EZH2 is essential for glioblastoma cancer stem cell maintenance. Cancer Res, 2009, 69, 9211-9218
63. Zhang, L.; Xie, J.; Wang, X.; Liu, X.; Tang, X.; Cao, R.; Hu, W.; Nie, S.; Fan, C.; Liang, S. Proteomic analysis of mouse liver plasma membrane: use of differential extraction to enrich hydrophobic membrane proteins. Proteomics, 2005, 5, 4510-4524
64. Chang, P. S.; Absood, A.; Linderman, J. J.; Omann, G. M. Magnetic bead isolation of neutrophil plasma membranes and quantification of membrane-associated guanine nucleotide binding proteins. Anal Biochem, 2004, 325, 175-184
65. Lawson, E. L.; Clifton, J. G.; Huang, F.; Li, X.; Hixson, D. C.; Josic, D. Use of magnetic beads with immobilized monoclonal antibodies for isolation of highly pure plasma membranes. Electrophoresis, 2006, 27, 2747-2758
66. Zhao, Y.; Zhang, W.; Kho, Y. Proteomic analysis of integral plasma membrane proteins. Anal Chem, 2004, 76, 1817-1823
67. Leth-Larsen, R.; Lund, R. R.; Ditzel, H. J. Plasma membrane proteomics and its application in clinical cancer biomarker discovery. Mol Cell Proteomics, 2010, 9, 1369-1382
68. Unwin, R. D.; Smith, D. L.; Blinco, D.; Wilson, C. L.; Miller, C. J.; Evans, C. A.; Jaworska, E.; Baldwin, S. A.; Barnes, K.; Pierce, A.; Spooncer, E.; Whetton, A. D. Quantitative proteomics reveals posttranslational control as a regulatory factor in primary hematopoietic stem cells. Blood, 2006, 107, 4687-4694
69. Ota, J.; Yamashita, Y.; Okawa, K.; Kisanuki, H.; Fujiwara, S.; Ishikawa, M.; Lim Choi, Y.; Ueno, S.; Ohki, R.; Koinuma, K.; Wada, T.; Compton, D.; Kadoya, T.; Mano, H. Proteomic analysis of hematopoietic stem cell-like fractions in leukemic disorders. Oncogene, 2003, 22, 5720-5728
70. Kratchmarova, I.; Blagoev, B.; Haack-Sorensen, M.; Kassem, M.; Mann, M. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science, 2005, 308, 1472-1477
71. Foster, L. J.; Zeemann, P. A.; Li, C.; Mann, M.; Jensen, O. N.; Kassem, M. Differential expression profiling of membrane proteins by quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast differentiation. Stem Cells, 2005, 23, 1367-1377
72. Nunomura, K.; Nagano, K.; Itagaki, C.; Taoka, M.; Okamura, N.; Yamauchi, Y.; Sugano, S.; Takahashi, N.; Izumi, T.; Isobe, T. Cell surface labeling and mass spectrometry reveal diversity of cell surface markers and signaling molecules expressed in undifferentiated mouse embryonic stem cells. Mol Cell Proteomics, 2005, 4, 1968-1976
73. Prokhorova, T. A.; Rigbolt, K. T.; Johansen, P. T.; Henningsen, J.; Kratchmarova, I.; Kassem, M.; Blagoev, B. Stable isotope labeling by amino acids in cell culture (SILAC) and quantitative comparison of the membrane proteomes of self-renewing and differentiating human embryonic stem cells. Mol Cell Proteomics, 2009, 8, 959-970
74. Rigbolt, K. T.; Prokhorova, T. A.; Akimov, V.; Henningsen, J.; Johansen, P. T.; Kratchmarova, I.; Kassem, M.; Mann, M.; Olsen, J. V.; Blagoev, B. System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci Signal, 2011, 4, rs3
75. Maurer, M. H.; Feldmann, R. E., Jr.; Futterer, C. D.; Butlin, J.; Kuschinsky, W. Comprehensive proteome expression profiling of undifferentiated versus differentiated neural stem cells from adult rat hippocampus. Neurochem Res, 2004, 29, 1129-1144
76. Cao, R.; Chen, K.; Song, Q.; Zang, Y.; Li, J.; Wang, X.; Chen, P.; Liang, S. Quantitative Proteomic Analysis of Membrane Proteins Involved in Astroglial Differentiation of Neural Stem Cells by SILAC Labeling Coupled with LC-MS/MS. J Proteome Res, 2012
77. Nilsson, C. L.; Dillon, R.; Devakumar, A.; Shi, S. D.; Greig, M.; Rogers, J. C.; Krastins, B.; Rosenblatt, M.; Kilmer, G.; Major, M.; Kaboord, B. J.; Sarracino, D.; Rezai, T.; Prakash, A.; Lopez, M.; Ji, Y.; Priebe, W.; Lang, F. F.; Colman, H.; Conrad, C. A. Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network: an initial study in GSC11 glioblastoma stem cells. J Proteome Res, 2010, 9, 430-443
78. He, J.; Liu, Y.; Zhu, T. S.; Xie, X.; Costello, M. A.; Talsma, C. E.; Flack, C. G.; Crowley, J. G.; Dimeco, F.; Vescovi, A. L.; Fan, X.; Lubman, D. M. Glycoproteomic analysis of glioblastoma stem cell differentiation. J Proteome Res, 2011, 10, 330-338
79. Dai, L.; Liu, Y.; He, J.; Flack, C. G.; Talsma, C. E.; Crowley, J. G.; Muraszko, K. M.; Fan, X.; Lubman, D. M. Differential profiling studies of N-linked glycoproteins in glioblastoma cancer stem cells upon treatment with gammasecretase inhibitor. Proteomics, 2011, 11, 4021-4028
80. Gilbertson, R. J.; Rich, J. N. Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat Rev Cancer, 2007, 7, 733-736
81. Calabrese, C.; Poppleton, H.; Kocak, M.; Hogg, T. L.; Fuller, C.; Hamner, B.; Oh, E. Y.; Gaber, M. W.; Finklestein, D.; Allen, M.; Frank, A.; Bayazitov, I. T.; Zakharenko, S. S.; Gajjar, A.; Davidoff, A.; Gilbertson, R. J. A perivascular niche for brain tumor stem cells. Cancer Cell, 2007, 11, 69-82
82. Zhu, T. S.; Costello, M. A.; Talsma, C. E.; Flack, C. G.; Crowley, J. G.; Hamm, L. L.; He, X.; Hervey-Jumper, S. L.; Heth, J. A.; Muraszko, K. M.; Di Meco, F.; Vescovi, A. L.; Fan, X. Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. Cancer Res, 2011, 71, 6061-6072
83. Wang, J.; Wakeman, T. P.; Lathia, J. D.; Hjelmeland, A. B.; Wang, X. F.; White, R. R.; Rich, J. N.; Sullenger, B. A. Notch promotes radioresistance of glioma stem cells. Stem Cells, 2010, 28, 17-28
84. Ricci-Vitiani, L.; Pallini, R.; Biffoni, M.; Todaro, M.; Invernici, G.; Cenci, T.; Maira, G.; Parati, E. A.; Stassi, G.; Larocca, L. M.; De Maria, R. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature, 2010, 468, 824-828
85. Kanamori, M.; Kawaguchi, T.; Nigro, J. M.; Feuerstein, B. G.; Berger, M. S.; Miele, L.; Pieper, R. O. Contribution of Notch signaling activation to human glioblastoma multiforme. J Neurosurg, 2007, 106, 417-427
86. Fan, X.; Khaki, L.; Zhu, T. S.; Soules, M. E.; Talsma, C. E.; Gul, N.; Koh, C.; Zhang, J.; Li, Y. M.; Maciaczyk, J.; Nikkhah, G.; Dimeco, F.; Piccirillo, S.; Vescovi, A. L.; Eberhart, C. G. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells, 2010, 28, 5-16
87. Sanai, N.; Alvarez-Buylla, A.; Berger, M. S. Neural stem cells and the origin of gliomas. N Engl J Med, 2005, 353, 811-822